Retatrutide
$85 10mg | $155 20mg
FOR RESEARCH USE ONLY
Retatrutide is a synthetic research peptide studied for its activity across three metabolic receptor pathways: GIP, GLP-1, and glucagon.
This triple-receptor profile has made retatrutide a major focus in metabolic research involving glucose regulation, appetite signaling, body composition models, energy balance, and cardiometabolic pathway analysis.
Because retatrutide activates incretin-related and glucagon-related signaling systems, it is commonly examined in research models involving obesity-related biology, insulin-response pathways, lipid metabolism, gastric-emptying models, and nutrient regulation.
Final order totals, availability, shipping, and payment instructions are confirmed by email before payment.
Additional Information
Retatrutide is a modified 39-amino-acid peptide commonly studied in laboratory and clinical research settings for its interaction with glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. These receptor systems are closely associated with incretin biology, glucose handling, appetite regulation, energy expenditure, and metabolic adaptation.
In research environments, retatrutide is often examined for how triple-receptor agonist compounds may influence metabolic systems differently than single or dual incretin-based compounds. GLP-1 receptor activity is commonly studied in relation to appetite signaling, insulin response, gastric-emptying models, and glucose regulation. GIP receptor activity is studied in relation to insulin secretion, adipose tissue signaling, and nutrient metabolism. Glucagon receptor activity is studied in relation to hepatic glucose output, lipid metabolism, energy expenditure, and broader metabolic regulation.
Retatrutide has gained significant research interest due to its use in models involving body weight regulation, obesity-related biology, cardiometabolic signaling, glucose homeostasis, liver-fat research, and metabolic flexibility. Because it targets multiple receptor systems at once, it is especially relevant in studies comparing single-receptor, dual-receptor, and triple-receptor metabolic peptide compounds.
At Vistara Labs, Retatrutide 20mg is supplied strictly for research use only and is intended for qualified laboratory, analytical, or educational research applications. It is not intended for human or veterinary use.
Key Research Areas
• Triple-receptor metabolic peptide research
• GLP-1, GIP, and glucagon receptor pathway studies
• Glucose homeostasis and insulin-response research
• Appetite signaling and energy-balance models
• Obesity-related and body composition research
• Gastric-emptying and nutrient-regulation models
• Lipid metabolism and energy expenditure studies
• Cardiometabolic signaling research
• Liver-fat and metabolic flexibility models
• Comparative incretin and glucagon pathway analysis
Product Info
Product name: Retatrutide
Amount: 20mg per vial
Molecular formula: C221H342N46O68
Molecular weight: Approximately 4731.3 g/mol
Molecular class: Modified 39-amino-acid peptide
Receptor profile: GIP, GLP-1, and glucagon receptor agonist
Purity: 99%+
Research use: For research use only, not for human or veterinary use